Prot #MVT-601-3003: LIBERTY EXTENSION: An International Phase 3 Open-Label, Single-Arm, Long-Term Efficacy and Safety Extension Study to Evaluate Relugolix Co-Administered with Low-Dose Estradiol and Norethindrone Acetate in Women with Heavy Menstrual Ble

Project: Research project

Project Details

StatusActive
Effective start/end date2/5/192/5/22

Funding

  • LBR Regulatory and Clinical Consulting Services, Inc. (Prot #MVT-601-3003)
  • Myovant Sciences, Inc. (Prot #MVT-601-3003)